IMARC Group’s latest report, titled “Artificial Heart-Lung Machine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, market reached a value of US$ 319.3 Million in 2020. The Global Artificial Heart-Lung Machine Market size to grow at a CAGR of 6.2% during 2021-2026. An artificial heart-lung machine (HLM), also known as a cardiopulmonary bypass pump, refers to an apparatus that performs the function of both the heart and lungs during open-heart surgery or a transplant. It ensures that the blood receives oxygen and removes carbon dioxide before the blood is pumped back into the body. It keeps the patient alive during heart transplants and has formed the basis of the medical support given to premature babies and those with respiratory or cardiac problems for extended periods. Some of the main components of an HLM include pump, heat exchanger, oxygenator, filter, temperature regulator and connecting tube.As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Get a sample copy of this Report: www.imarcgroup.com/artificial-heart-lung-machine-market/requestsample
Global Artificial Heart-Lung Machine Market Trends:
According to the 2016 estimates of the World Health Organization (WHO), approximately 17.9 million people die from cardiovascular diseases (CVDs) per year, representing 31% of all the global deaths. The high prevalence of CVDs, along with improved access to healthcare facilities, has led to a consequent rise in the number of open-heart surgeries or coronary interventions performed worldwide, which in turn has increased the demand for HLMs. Apart from this, the leading firms are engaged in continuous innovation with global research and development (R&D) centers for introducing better technologies to improve patient heart conditions. For instance, LivaNova, a global medical technology company, has designed machines ranging from small, compact HLMs equipped with three roller pumps to full-featured systems with seven roller pumps and the full range of control and monitoring functions.
View Full Report with TOC & List of Figure: www.imarcgroup.com/artificial-heart-lung-machine-market
Competitive Landscape with Key players:
The report has also analysed the competitive landscape of the market with some of the key players being.
Medtronic Inc
Sorin Group
MAQUET GmbH & Co. KG
Terumo Corporation
R. Bard Inc
Tianjin Medical
Edwards Lifesciences
Jarvik Heart
Braile Biomédica
SynCardia
Artificial Heart-Lung Machine Market Segmentation:
Our report has categorized the market based on Region, Type, Application and End use industry.
Market Breakup by Type:
Single Roller Pump
Double Roller Pump
Market Breakup by Application:
Cardiac Surgeries
Lung Surgeries
Acute Respiratory Failure Treatment
Others
Market Breakup by End User:
Hospitals and Clinics
Ambulatory Surgical Centers
Others
Breakup by Region:
North America (United States, Canada)
Europe (Germany, France, United Kingdom, Italy, Spain, Others)
Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)